174 related articles for article (PubMed ID: 32146613)
21. [Acute adrenal insufficiency during unilateral adrenal hemorrhage secondary to the antiphospholipid syndrome].
Blanc PL; Forel C; Jay S; Susset V
Rev Med Interne; 2006 Dec; 27(12):970-2. PubMed ID: 16997432
[TBL] [Abstract][Full Text] [Related]
22. Definitive adrenal insufficiency due to bilateral adrenal hemorrhage and primary antiphospholipid syndrome.
Caron P; Chabannier MH; Cambus JP; Fortenfant F; Otal P; Suc JM
J Clin Endocrinol Metab; 1998 May; 83(5):1437-9. PubMed ID: 9589635
[No Abstract] [Full Text] [Related]
23. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid syndrome: endocrinologic manifestations and organ involvement.
Mehdi AA; Salti I; Uthman I
Semin Thromb Hemost; 2011 Feb; 37(1):49-57. PubMed ID: 21305801
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
[TBL] [Abstract][Full Text] [Related]
26. [Adrenal insufficiency].
Joly M; Lefebvre H; Kuhn JM
Rev Prat; 1998 Apr; 48(7):724-30. PubMed ID: 11767366
[TBL] [Abstract][Full Text] [Related]
27. Adrenal insufficiency complicated with antiphospholipid syndrome (APS).
Fujishima N; Komatsuda A; Ohyagi H; Fujishima M; Tada M; Ohtani H; Wakui H; Hirokawa M; Sawada K
Intern Med; 2006; 45(16):963-6. PubMed ID: 16974059
[TBL] [Abstract][Full Text] [Related]
28. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients.
Ramon I; Mathian A; Bachelot A; Hervier B; Haroche J; Boutin-Le Thi Huong D; Costedoat-Chalumeau N; Wechsler B; Karmali R; Velkeniers B; Touraine P; Coussieu C; Bennani A; Renard-Penna R; Grenier PA; Wahl D; Piette JC; Amoura Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):3179-89. PubMed ID: 23783099
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review.
Meade-Aguilar JA; Figueroa-Parra G; Yang JX; Langenfeld HE; González-Treviño M; Dogra P; Bancos I; Moynagh MR; Murad MH; Prokop LJ; Hanson AC; Crowson CS; Duarte-García A
Clin Immunol; 2024 Mar; 260():109906. PubMed ID: 38244823
[TBL] [Abstract][Full Text] [Related]
30. [Antibodies directed against adrenal glands in Addison's and Cushing's diseases].
Jeske W; Gajl-Peczalska K; Kasperlik-Zaluska A
Pol Arch Med Wewn; 1971 Nov; 47(5):485-91. PubMed ID: 5133428
[No Abstract] [Full Text] [Related]
31. Primary antiphospholipid antibody syndrome presenting with adrenal insufficiency in a child: case report and review of literature.
Bhakhri BK; Katewa S; Sharma R; Mahajan S
Lupus; 2011 Oct; 20(11):1203-8. PubMed ID: 21505010
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review].
Pons I; Espinosa G; Cervera R
Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717
[TBL] [Abstract][Full Text] [Related]
33. Adrenal failure and antiphospholipid syndrome.
Mlekuš Kozamernik K; Jensterle M; Ambrožič A; Pfeifer M
J Int Med Res; 2020 Jul; 48(7):300060520903659. PubMed ID: 32692293
[TBL] [Abstract][Full Text] [Related]
34. ARDS and adrenal insufficiency associated with the antiphospholipid antibody syndrome.
Argento A; DiBenedetto RJ
Chest; 1998 Apr; 113(4):1136-8. PubMed ID: 9554663
[TBL] [Abstract][Full Text] [Related]
35. Identification and treatment of APS renal involvement.
Tektonidou MG
Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
[TBL] [Abstract][Full Text] [Related]
36. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
[TBL] [Abstract][Full Text] [Related]
37. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
Kato M; Hisada R; Atsumi T
Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
[TBL] [Abstract][Full Text] [Related]
39. Managing antiphospholipid antibodies and antiphospholipid syndrome in children.
Kamat AV; D'Cruz DP; Hunt BJ
Haematologica; 2006 Dec; 91(12):1674-80. PubMed ID: 17145604
[TBL] [Abstract][Full Text] [Related]
40. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.
Kampolis C; Tektonidou M; Moyssakis I; Tzelepis GE; Moutsopoulos H; Vlachoyiannopoulos PG
Semin Arthritis Rheum; 2014 Feb; 43(4):558-65. PubMed ID: 24012042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
